iShares iBonds Dec 2027 Term Corporate ETF $IBDS Shares Bought by Rebalance LLC

Rebalance LLC raised its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDSFree Report) by 54.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 701,255 shares of the company’s stock after acquiring an additional 248,527 shares during the quarter. iShares iBonds Dec 2027 Term Corporate ETF makes up 1.0% of Rebalance LLC’s investment portfolio, making the stock its 15th largest position. Rebalance LLC’s holdings in iShares iBonds Dec 2027 Term Corporate ETF were worth $17,069,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of IBDS. Atlantic Union Bankshares Corp acquired a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF during the 2nd quarter worth about $6,172,000. Confluence Investment Management LLC raised its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 155.7% during the third quarter. Confluence Investment Management LLC now owns 416,135 shares of the company’s stock valued at $10,129,000 after acquiring an additional 253,368 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 18.7% during the second quarter. Ameriprise Financial Inc. now owns 1,501,886 shares of the company’s stock valued at $36,442,000 after acquiring an additional 236,150 shares during the last quarter. Valeo Financial Advisors LLC purchased a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF in the second quarter valued at approximately $3,083,000. Finally, Lbmc Investment Advisors LLC increased its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 58.7% during the second quarter. Lbmc Investment Advisors LLC now owns 195,185 shares of the company’s stock worth $4,737,000 after purchasing an additional 72,232 shares in the last quarter.

iShares iBonds Dec 2027 Term Corporate ETF Price Performance

NYSEARCA IBDS opened at $24.26 on Friday. The business has a fifty day moving average price of $24.30 and a 200 day moving average price of $24.26. iShares iBonds Dec 2027 Term Corporate ETF has a one year low of $23.89 and a one year high of $24.52.

About iShares iBonds Dec 2027 Term Corporate ETF

(Free Report)

The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.

Featured Articles

Want to see what other hedge funds are holding IBDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDSFree Report).

Institutional Ownership by Quarter for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS)

Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.